Molina Healthcare Q2 adjusted EPS near $5.50 below expectations; 2025 outlook updated
Molina Healthcare said preliminary second-quarter 2025 adjusted earnings are about $5.50 per share, modestly below its prior expectations, citing medical cost pressures in all three lines of business. It also updated full-year 2025 adjusted EPS guidance to $21.50 to $22.50, a consolidated pre-tax margin of just under 4%, which is the low end of its long-term range, and expects the cost pressures to continue into the second half.
Key points
- Preliminary Q2 2025 adjusted EPS of approximately $5.50; GAAP net income of approximately $259 million, or $4.83 per diluted share
- Full-year 2025 adjusted EPS guidance of $21.50 to $22.50, versus GAAP net income guidance of $1,045 million to $1,099 million
- Medical cost pressures expected to continue into the second half of 2025
- Full second-quarter results to be released after market close on July 23, 2025
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:56 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 07, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.